Filing Details

Accession Number:
0001209191-17-061613
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-11-17 18:42:46
Reporting Period:
2017-11-15
Accepted Time:
2017-11-17 18:42:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1435049 Aduro Biotech Inc. ADRO Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1465994 Jennifer Lew C/O Aduro Biotech, Inc.
740 Heinz Avenue
Berkeley CA 94710
Sr. Vice President Of Finance No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-11-15 6,600 $0.82 68,938 No 4 M Direct
Common Stock Disposition 2017-11-15 6,600 $8.95 62,338 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2017-11-15 6,600 $0.00 6,600 $0.82
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
57,309 2023-11-26 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were affected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 26, 2017.
  2. The shares subject to the Option are fully vested and immediately exercisable.